Quarterly report pursuant to Section 13 or 15(d)

DEVELOPMENT PARTNER ARRANGEMENTS (Details)

v3.21.2
DEVELOPMENT PARTNER ARRANGEMENTS (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 23, 2020
USD ($)
Nov. 13, 2019
USD ($)
Dec. 13, 2018
USD ($)
Mar. 31, 2021
USD ($)
Jun. 30, 2021
USD ($)
Dec. 31, 2020
USD ($)
Apr. 30, 2019
USD ($)
Oct. 16, 2015
USD ($)
phase
employee
Research and Development Arrangement, Contract to Perform for Others [Line Items]                
Deferred research and development obligation         $ 1,000 $ 1,000    
Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | P&G                
Research and Development Arrangement, Contract to Perform for Others [Line Items]                
Number of phases outlined by research and development agreement | phase               3
Number of full-time employees to assist in execution of research and development activities, phase one | employee               1
Number of full-time employees to assist in execution of research and development activities, phase two | employee               2
Prepaid royalties and licenses         2,000 2,000 $ 2,000  
Obligation to pay for services               $ 500
Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Impact                
Research and Development Arrangement, Contract to Perform for Others [Line Items]                
Initial license fee   $ 2,500            
Payment for license agreement       $ 890 1,600      
Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Total                
Research and Development Arrangement, Contract to Perform for Others [Line Items]                
Prepayment for block and release agreement $ 5,000              
Block and release agreement, capital funding, minimum requirement 370,000              
Escrow released $ 5,000              
Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Nestle                
Research and Development Arrangement, Contract to Perform for Others [Line Items]                
Payment committed to fund further research and development     $ 1,000          
Maximum funding convertible, percent     50.00%          
Term loan obligation     5 years          
Deferred research and development obligation         $ 1,000 $ 1,000